TABLE 1.
Bacterial strains used in this study
| Strain | Isolation date (mo/day/yr) | Source | Description | MLST | Reference(s) or sourcea |
|---|---|---|---|---|---|
| 126 | 8/24/1993 | Blood | Buffalo, NY; from T. Russo | 62 | This study |
| EV98 | 3/1/1999 | Blood | Hospital isolate | 155 | 46, 47 |
| EV609 | 4/4/1999 | Blood | Hospital isolate | 151 | 46, 47 |
| 28 | 3/8/1993 | Blood | Buffalo, NY; from T. Russo | 21 | This study |
| W32944 | Unknown | Urine | Unknown | 21 | 9 |
| EV68 | 3/1/1999 | Blood | Hospital isolate | 21 | 46, 47 |
| E1198 | Unknown | Blood | 22A108; clinical isolate, Turkey | 21 | ENARE |
| E0115 | 1997 | Feces | 9700334; community survey, The Netherlands | 145 | NIVEL |
| EV479 | 4/4/1999 | Blood | Hospital isolate | 157 | 46, 47 |
| EV172 | 3/1/1999 | Blood | Hospital isolate | 41 | 46, 47 |
| EV108 | 3/1/1999 | Blood | Hospital isolate | 146 | 46, 47 |
| 613 | 1994 | Endocarditis | MC0098; from M. Huycke | 19 | This study |
| T16 | ≤1951 | Infant/fecal | NCTC 8729, s161 type 3, United Kingdom | 19 | 28-30, 41, 49, 50 |
| E19 | 10/4/1999 | Urine | Little Rock, AK | 4 | This study |
| E99 | 1/14/2000 | Urine | Little Rock, AK | 4 | This study |
| NZ4 | 2001-2002 | Blood | Christchurch, New Zealand; from D. Murdoch | 152 | This study |
| 545 | 1989 | Urine | U17248; Oklahoma City, OK; from M. Huycke | 6 | This study |
| MMH594 | 1985 | Blood | Wisconsin | 6 | 16, 30, 38 |
| V583 | 2/12/1987 | Blood | ATCC 700802; St. Louis, MO | 6 | 30, 37 |
| V586 | 2/23/1987 | Blood | St. Louis, MO | 6 | 37 |
| EV408 | 3/24/1999 | Blood | Hospital isolate | 155 | 46, 47 |
| T4 | ≤1992 | Urine | Otaru-104; Otaru, Japan | 62 | 28-30, 49, 50 |
| E103 | 1/18/2000 | Urine | Little Rock, AK | 64 | This study |
| EV596 | 4/4/1999 | Blood | Hospital isolate | 64 | 46, 47 |
| 79-3 | 10/4/1999 | Blood | Chicago, IL | 64 | 30 |
| EV586 | 4/4/1999 | Blood | Hospital isolate | 8 | 46, 47 |
| EV147 | 3/1/1999 | Blood | Hospital isolate | 154 | 46, 47 |
| EV217-2 | 4/4/1999 | Blood | Hospital isolate | 153 | 46, 47 |
| E71 | 12/8/1999 | Urine | Little Rock, AK | 9 | This study |
| EV638 | 4/4/1999 | Blood | Hospital isolate | 9 | 46, 47 |
| Ned10 | 1961 | Horse | D5278/61; The Netherlands | 9 | 30 |
| YI6-1 | ≤1992 | Clinical | Japan | 28 | 17 |
| D6 | Unknown | Pig | 73-30318-4; Denmark | 16 | 30, 39 |
| A25 | 10/13/1989 | Urine | 3A1025; from Pfizer | 30 | This study |
| Ned2 | 1956 | Throat | D939/56; The Netherlands; from R. Willems | 156 | This study |
| D3 | Unknown | Pig | 73-30245-2; Denmark | 47 | 30, 39 |
| EV650 | 4/4/1999 | Blood | Hospital isolate | 40 | 46, 47 |
| EV419 | 3/24/1999 | Blood | Hospital isolate | 40 | 46, 47 |
| EV447 | 4/4/1999 | Blood | Hospital isolate | 40 | 46, 47 |
| EV632 | 4/4/1999 | Blood | Hospital isolate | 40 | 46, 47 |
| 326 | 7/14/1986 | Blood | 2081; from M. Huycke | 40 | This study |
| E73 | 12/10/1999 | Urine | Little Rock, AK | 40 | This study |
| V105 | Unknown | Animal | From Pfizer | 40 | This study |
| D1 | Unknown | Pig | 73-30082-2; Denmark | 40 | 30, 39 |
| A-3-1 | Early 1980s | Infant/sepsis | Denver, CO | 40 | 27, 30 |
| NZ10 | 2001-2002 | Blood | Christchurch, New Zealand; from D. Murdoch | 150 | This study |
| A27 | 10/13/1989 | Urine | 3A1027; from Pfizer | 148 | This study |
| NZ7 | 2001-2002 | Blood | Christchurch, New Zealand; from D. Murdoch | 144 | This study |
| 620 | 1994 | Endocarditis | MC0105; from M. Huycke | 144 | This study |
| EV321 | 3/1/1999 | Blood | Hospital isolate | 144 | 46, 47 |
| EV564 | 4/4/1999 | Blood | Hospital isolate | 55 | 46, 47 |
| 296 | 9/7/1986 | Blood | 2343: from M. Huycke | 149 | This study |
| D18 | Unknown | Human | 14821-V-2; Denmark; from L. B. Jensen | 147 | This study |
| OG1 | ≤1975 | Oral | ATCC 47077 | 1 | 10, 15, 30 |
| FA2-2 | ≤1973 | Clinical | United Kingdom; Rif/Fus-resistant mutant derived from plasmid-free strain JH2 | 8 | 5, 19, 30 |
a
ENARE, European Network for Antibiotic Resistance and Epidemiology; NIVEL, The Netherlands Institute for Health Services Research.